Piperlongumine targets NF-κB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer - PubMed (original) (raw)
. 2021 Apr;476(4):1765-1781.
doi: 10.1007/s11010-020-04044-7. Epub 2021 Jan 12.
Affiliations
- PMID: 33433833
- DOI: 10.1007/s11010-020-04044-7
Piperlongumine targets NF-κB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer
Sandeep Kumar et al. Mol Cell Biochem. 2021 Apr.
Abstract
NF-κB is the principle transcription factor and plays the central role in orchestrating chronic inflammation by regulating levels of cytokines, chemokines and growth factors. Piperlongumine (PL), a major alkaloid in the fruit of Piper longum Linn. has gained worldwide attention for its anticancer properties, however, its mechanism of action in the chemoprevention of colon cancer has not been investigated yet. Therefore, the present study was designed to elucidate the underlying molecular mechanism of PL in preventing DMH/DSS induced experimental colon cancer in mice. In the current study well established DMH/DSS induced experimental colon cancer mouse model was used to demonstrate the chemopreventive potential of PL. The expression of NF-κB and its downstream target proteins was evaluated mainly through western blotting. In addition, CAM assay, immunohistochemical staining and gelatin zymography was used to show anti-angiogenic and anti-invasive potential of PL. Additionally, important tumor biomarkers such as TSA, LASA, LDH and IL-6 levels were also estimated. The results of current study showed that PL was capable to inhibit NF-κB activation as well as its nuclear translocation. PL administration to DMH/DSS treated mice also inhibited the NF-κB downstream signaling cascades such as including COX-2 pathway, JAK/STAT pathway, β-catenin, Notch signaling pathway, angiogenesis and epithelial to mesenchymal transition pathway. The findings of the present study have claimed PL as promising chemopreventive agent for colon cancer with pleiotropic action. The current study emphasizes that regular consumption of PL can be an effective approach in the prevention of colon cancer in humans.
Keywords: Angiogenesis; Chronic inflammation; Colorectal cancer; Metastasis; NF-κB signaling pathway; Piperlongumine.
Similar articles
- Piperlongumine: the amazing amide alkaloid from Piper in the treatment of breast cancer.
Mitra S, Biswas P, Bandyopadhyay A, Gadekar VS, Gopalakrishnan AV, Kumar M, Radha, Nandy S. Mitra S, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2637-2650. doi: 10.1007/s00210-023-02673-5. Epub 2023 Nov 13. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37955690 Review. - Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.
Kumar S, Agnihotri N. Kumar S, et al. Biomed Pharmacother. 2019 Jan;109:1462-1477. doi: 10.1016/j.biopha.2018.10.182. Epub 2018 Nov 13. Biomed Pharmacother. 2019. PMID: 30551398 - Development and mechanism investigation of a new piperlongumine derivative as a potent anti-inflammatory agent.
Sun LD, Wang F, Dai F, Wang YH, Lin D, Zhou B. Sun LD, et al. Biochem Pharmacol. 2015 Jun 1;95(3):156-69. doi: 10.1016/j.bcp.2015.03.014. Epub 2015 Apr 4. Biochem Pharmacol. 2015. PMID: 25850000 - Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis.
Manigandan K, Manimaran D, Jayaraj RL, Elangovan N, Dhivya V, Kaphle A. Manigandan K, et al. Biochimie. 2015 Dec;119:103-12. doi: 10.1016/j.biochi.2015.10.014. Epub 2015 Oct 19. Biochimie. 2015. PMID: 26482805 - Piperlongumine and its derivatives against cancer: A recent update and future prospective.
Swain SS, Sahoo SK. Swain SS, et al. Arch Pharm (Weinheim). 2024 Jul;357(7):e2300768. doi: 10.1002/ardp.202300768. Epub 2024 Apr 9. Arch Pharm (Weinheim). 2024. PMID: 38593312 Review.
Cited by
- Piperlongumine: the amazing amide alkaloid from Piper in the treatment of breast cancer.
Mitra S, Biswas P, Bandyopadhyay A, Gadekar VS, Gopalakrishnan AV, Kumar M, Radha, Nandy S. Mitra S, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2637-2650. doi: 10.1007/s00210-023-02673-5. Epub 2023 Nov 13. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37955690 Review. - Experimental Murine Models for Colorectal Cancer Research.
Neto Í, Rocha J, Gaspar MM, Reis CP. Neto Í, et al. Cancers (Basel). 2023 Apr 30;15(9):2570. doi: 10.3390/cancers15092570. Cancers (Basel). 2023. PMID: 37174036 Free PMC article. Review. - The role of TNF-α and NFkβ in an experimental model of intestinal carcinogenesis with 1,2-dimethyhydrazine.
Barreira MA, Campelo MWS, Rebouças CDSM, Campelo APBS, Vasconcelos PRL. Barreira MA, et al. Acta Cir Bras. 2023 Sep 18;38:e383623. doi: 10.1590/acb383623. eCollection 2023. Acta Cir Bras. 2023. PMID: 37729351 Free PMC article. - Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review.
Fakhri S, Moradi SZ, Faraji F, Kooshki L, Webber K, Bishayee A. Fakhri S, et al. Cancer Metastasis Rev. 2024 Mar;43(1):501-574. doi: 10.1007/s10555-023-10136-9. Epub 2023 Oct 4. Cancer Metastasis Rev. 2024. PMID: 37792223 Review. - Piperlongumine regulates genes involved in the skin barrier in epidermal keratinocyte HaCaT cells.
Lee KH, Kang DG, Kim DW, Do HK, Kim DY, Kim W. Lee KH, et al. Anim Cells Syst (Seoul). 2024 Jun 25;28(1):326-339. doi: 10.1080/19768354.2024.2361144. eCollection 2024. Anim Cells Syst (Seoul). 2024. PMID: 38933927 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials